Delivery Order SPE2DB20D9135-SPE2DB22FD2XJ
Award Date
2/17/22
Potential Completion Date
3/11/22
Potential Value
$7.6K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The $3,573.45 task order is for the delivery of 4,565,781,416 NEXPLANON 68 MG implants, a contraceptive product, to fulfill the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA under the...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 68 mg Nexplanon contraceptive implants. The contract, valued at $14,293.80, has a completion date of June 4, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) worth up to $499,999,999, awarded to DMS Pharmaceutical Group by DLA under the SPE2DB program. The IDC allows DLA to issue delivery orders for...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The $7,146.90 contract is for the delivery of Nexplanon 68 mg implants to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract with the DLA, which allows the agency to issue firm fixed-price...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $30,661.50 contract is for the delivery of Nexplanon 68 MG Implants, a contraceptive product, to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,576.28 contract is for the delivery of 68 mg Nexplanon contraceptive implants, with an ultimate completion date of August 7, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a $5,717.52 firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The contract covers the supply of Nexplanon 68 mg implants, a type of contraceptive, to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,573.45 award is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive medical device, with a completion date of June 6, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the DLA's SPE2DB program. The $8,576.28 award is for the supply of Nexplanon 68 mg implants, a contraceptive product. DMS Pharmaceutical Group has a significant $499,999,999 indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) to provide a comprehensive range of pharmaceutical items, including common medications and specialized drugs, to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $10,720.35, is for the delivery of 4566420421 units of the Nexplanon 68 mg implant, a contraceptive device. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,146.90 contract is for the delivery of Nexplanon 68 mg implants, a contraceptive product, with a period of performance through May 28, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows...